Study Stopped
difficulty recruiting
Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle
Mioxsys ox
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Evaluate the influence of antioxidant men supplements treatment (Fertybiotic Hombre) in the rate of sORP (stactic Oxidation Reduction Potential) defined as the balanced measure between the total oxidant activity (ROS, superoxides, nitric oxide, peroxide) and total reducing activity (alpha tocopherol, β carotene, uric acid) in sperm samples during egg donation cycles. We will also evaluate the influence of the sORP rate in the embryo development during the egg donation treatments; taking in account the fecundation rate, percentage of blastocyst stage arrival embryos, number of frozen embryos, implantation rate, on-going pregnancy rate and miscarriage rate. The sperm sample will be measured by electrochemical technology using Mioxsys system for a quantitative measurement in millivolts (mV), in those male patients who participate in an egg donation assisted reproduction treatment. After 14 days, the pregnancy stage will be available. This information will be obtained from the patient's clinical history using the human chorionic gonadotropin hormone (shCG) in blood. It will be performed either in our Clinic or externally within the usual practice derived from the treatment carried out. These values will be compared with the results obtained from sORP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2019
CompletedFirst Submitted
Initial submission to the registry
March 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedFebruary 17, 2021
February 1, 2021
5 months
March 9, 2020
February 12, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Compare the sORP rate in sperm samples,
Compare the sORP rate in sperm samples, obtained by the Mioxsys System, before and after 2.5 months antioxidant men supplements treatment (Fertybiotic MAN).
2.5 months
Secondary Outcomes (3)
Evaluate the influence of the sORP rate in embryo development
1 year
Evaluate the relationship between the sORP rate in sperm samples
1 year
Determinate a reproductive prognosis value based on sORP rate and the different sperm parameters
1 year
Study Arms (1)
Antioxidant Treatment
EXPERIMENTALInfluence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men
Interventions
Oral antioxidant oral intake in the 3 months prior to inclusion in the study
Eligibility Criteria
You may qualify if:
- Sperm count greater than 2 million per milliliter
- Sperm origin: ejaculate
You may not qualify if:
- Total astenozoospermia or Severe teratozoospermia (including balloonzoospermia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IVI Bilbaolead
- Aytu BioPharma, Inc.collaborator
Study Sites (1)
IVI Bilbao
Leioa, Vizcaya, 48940, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcos Ferrando
IVI Bilbao
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Marcos Ferrando Serrano
Study Record Dates
First Submitted
March 9, 2020
First Posted
February 17, 2021
Study Start
February 12, 2019
Primary Completion
July 18, 2019
Study Completion
February 12, 2021
Last Updated
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share